These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Surveillance of the safety of simultaneous administration of vaccines. The Centers for Disease Control and Prevention experience. Chen RT; Haber P; Mullen JR Ann N Y Acad Sci; 1995 May; 754():309-20. PubMed ID: 7625667 [No Abstract] [Full Text] [Related]
67. International prospects for combined vaccines with emphasis on quadrivalent diphtheria-tetanus-pertussis-hepatitis B vaccine. Melnick JL Ann N Y Acad Sci; 1995 May; 754():267-72. PubMed ID: 7625661 [No Abstract] [Full Text] [Related]
72. [Pilot study on compulsory vaccination coverage]. Grandolfo ME; Lauria L; Medda E; Bucciarelli M; Andreozzi S; Salinetti S; Sitzia G; Bernacchia R Ann Ist Super Sanita; 1999; 35(2):341-7. PubMed ID: 10645670 [TBL] [Abstract][Full Text] [Related]
73. From the Centers for Disease Control and Prevention. Supply diphtheria and tetanus toxoids and acellular pertussis vaccine. JAMA; 2002 Feb; 287(5):579. PubMed ID: 11838447 [No Abstract] [Full Text] [Related]
74. From the Centers for Disease Control. FDA approval of use of diphtheria and tetanus toxoids and acellular pertussis vaccine. JAMA; 1992 Jan 22-29; 267(4):485. PubMed ID: 1729566 [No Abstract] [Full Text] [Related]
75. From the Centers of Disease Control and Prevention. Recommended childhood immunization schedule--United States, 2002. JAMA; 2002 Feb; 287(6):707-8. PubMed ID: 11855384 [No Abstract] [Full Text] [Related]
76. From the Centers for Disease Control. FDA approval of second diphtheria, tetanus toxoids, and acellular pertussis vaccine. JAMA; 1992 Oct; 268(14):1834, 1837. PubMed ID: 1404700 [No Abstract] [Full Text] [Related]
77. From the Centers for Disease Control and Prevention. Update: recommendations to prevent hepatitis B virus transmission--United States. JAMA; 1999 Mar; 281(9):790. PubMed ID: 10070986 [No Abstract] [Full Text] [Related]
78. Subpotent vaccine lot recalled, recommendations on supplemental doses issued. Am J Health Syst Pharm; 1999 Mar; 56(6):504. PubMed ID: 10192682 [No Abstract] [Full Text] [Related]
80. From the Centers for Disease Control and Prevention. FDA approval of a second acellular pertussis vaccine for use among infants and young children. JAMA; 1997 Mar; 277(10):783. PubMed ID: 9052694 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]